SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals informs about issue of securities

15 Sep 2021 Evaluate

Fredun Pharmaceuticals has informed that a meeting of the Board of Directors is scheduled to be held on Saturday, 18th September, 2021 at 11:00 am to consider the following: Issue of equity shares/ warrants/ fully convertible debentures or any other financial instrument which would be converted into/ exchanged with equity shares at a later date, under Preferential Guidelines of SEBI to promoters and other eligible investors; to consider and approve the matter of holding an EGM/ Postal Ballot; to consider the matter of making an application to BSE for in-principle approval; and any other matter with the permission of the Chair.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

2297.80 -11.05 (-0.48%)
08-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1788.60
Dr. Reddys Lab 1275.75
Cipla 1388.25
Zydus Lifesciences 1087.45
Lupin 2252.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×